Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Triple Negative Breast Neoplasms 1Rare Tumour 1Nasopharyngeal Carcinoma 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1Esophageal Squamour Cell Cancer 1Advanced Breast Cancer 1

Interventions

Injections 2Fulvestrant 2trastuzumab deruxtecan 1toripalimab 1palbociclib 1dalpiciclib 1Sirolimus 1Paclitaxel 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Advanced Breast Cancer × palbociclib × Clear all
NCT06941142 2025-04-23

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Not yet recruiting
382 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡